{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,20]],"date-time":"2026-06-20T06:02:50Z","timestamp":1781935370705,"version":"3.54.5"},"reference-count":22,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2023,10,4]]},"DOI":"10.7759\/cureus.46477","type":"journal-article","created":{"date-parts":[[2023,10,4]],"date-time":"2023-10-04T16:35:37Z","timestamp":1696437337000},"source":"Crossref","is-referenced-by-count":4,"title":["The Effect of Direct Oral Anticoagulants on Gastric Mucosa and Helicobacter Pylori Prevalence in Dyspeptic Patients: A Retrospective Cross-Sectional Study"],"prefix":"10.7759","author":[{"given":"Kubilay","family":"Issever","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ersin","family":"Kuloglu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ali","family":"Muhtaroglu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Demet","family":"Seker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Osman","family":"Kotur","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ahmet Cumhur","family":"Dulger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1001\/jamacardio.2022.1292","article-title":"Efficacy and safety considerations with dose-reduced direct oral anticoagulants: a review","volume":"7","author":"Bikdeli B","year":"2022","unstructured":"Bikdeli B, Zahedi Tajrishi F, Sadeghipour P, et al.. Efficacy and safety considerations with dose-reduced direct oral anticoagulants: a review. JAMA Cardiol. 2022, 7:747-59. 10.1001\/jamacardio.2022.1292","journal-title":"JAMA Cardiol"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(20)32439-9","article-title":"Direct oral anticoagulants: evidence and unresolved issues","volume":"396","author":"Chan N","year":"2020","unstructured":"Chan N, Sobieraj-Teague M, Eikelboom JW. Direct oral anticoagulants: evidence and unresolved issues. Lancet. 2020, 396:1767-76. 10.1016\/S0140-6736(20)32439-9","journal-title":"Lancet"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.3390\/medicina56070363","article-title":"The impact of novel anticoagulants on the upper gastrointestinal tract mucosa","volume":"56","author":"Mihalkanin L","year":"2020","unstructured":"Mihalkanin L, Stancak B. The impact of novel anticoagulants on the upper gastrointestinal tract mucosa. Medicina (Kaunas). 2020, 56:10.3390\/medicina56070363","journal-title":"Medicina (Kaunas)"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.114.012808","article-title":"Cardiology patient page. Patient guide for taking the non-vitamin K antagonist oral anticoagulants for atrial fibrillation","volume":"131","author":"Lane DA","year":"2015","unstructured":"Lane DA, Wood K. Cardiology patient page. Patient guide for taking the non-vitamin K antagonist oral anticoagulants for atrial fibrillation. Circulation. 2015, 131:e412-5. 10.1161\/CIRCULATIONAHA.114.012808","journal-title":"Circulation"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1007\/s10120-020-01105-0","article-title":"Influence of anticoagulants on the risk of delayed bleeding after gastric endoscopic submucosal dissection: a multicenter retrospective study","volume":"24","author":"Tomida H","year":"2021","unstructured":"Tomida H, Yoshio T, Igarashi K, et al.. Influence of anticoagulants on the risk of delayed bleeding after gastric endoscopic submucosal dissection: a multicenter retrospective study. Gastric Cancer. 2021, 24:179-89. 10.1007\/s10120-020-01105-0","journal-title":"Gastric Cancer"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1016\/j.ahjo.2022.100203","article-title":"Twice- or once-daily dosing of direct oral anticoagulants and gastrointestinal bleeding in patient with atrial fibrillation","volume":"22","author":"Ido T","year":"2022","unstructured":"Ido T, Sasaki S, Sotomi Y, et al.. Twice- or once-daily dosing of direct oral anticoagulants and gastrointestinal bleeding in patient with atrial fibrillation. Am Heart J Plus: Cardiol Res Pract. 2022, 22:100203. 10.1016\/j.ahjo.2022.100203","journal-title":"Am Heart J Plus: Cardiol Res Pract"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1160\/TH13-02-0150","article-title":"Gastrointestinal bleeding with the new oral anticoagulants--defining the issues and the management strategies","volume":"110","author":"Desai J","year":"2013","unstructured":"Desai J, Kolb JM, Weitz JI, Aisenberg J. Gastrointestinal bleeding with the new oral anticoagulants--defining the issues and the management strategies. Thromb Haemost. 2013, 110:205-12. 10.1160\/TH13-02-0150","journal-title":"Thromb Haemost"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.4324\/9780203771587","article-title":"Statistical Power Analysis for the Behavioral Sciences","author":"Cohen J.","year":"1988","unstructured":"Cohen J.. Statistical Power Analysis for the Behavioral Sciences. Lawrence Erlbaum Associates, Hillsdale, New Jersey; 1988. 10.4324\/9780203771587"},{"key":"ref9","article-title":"Using Multivariate Statistics","author":"Tabachnick BG","year":"2013","unstructured":"Tabachnick BG, Fidell LS. Using Multivariate Statistics. Pearson, Boston, MA; 2013."},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1007\/s40264-018-0668-9","article-title":"Non-bleeding adverse events with the use of direct oral anticoagulants: a sequence symmetry analysis","volume":"41","author":"Maura G","year":"2018","unstructured":"Maura G, Billionnet C, Coste J, Weill A, Neumann A, Pariente A. Non-bleeding adverse events with the use of direct oral anticoagulants: a sequence symmetry analysis. Drug Saf. 2018, 41:881-97. 10.1007\/s40264-018-0668-9","journal-title":"Drug Saf"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1016\/j.jemermed.2012.02.042","article-title":"Hemorrhagic gastritis with dabigatran in a patient with renal insufficiency","volume":"44","author":"Fellows SE","year":"2013","unstructured":"Fellows SE, Rosini JM, Curtis JA, Volz EG. Hemorrhagic gastritis with dabigatran in a patient with renal insufficiency. J Emerg Med. 2013, 44:e221-5. 10.1016\/j.jemermed.2012.02.042","journal-title":"J Emerg Med"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.7326\/M21-1474","article-title":"Rivaroxaban is associated with higher rates of gastrointestinal bleeding than other direct oral anticoagulants: a nationwide propensity score-weighted study","volume":"174","author":"Ingason AB","year":"2021","unstructured":"Ingason AB, Hreinsson JP, \u00c1g\u00fastsson AS, et al.. Rivaroxaban is associated with higher rates of gastrointestinal bleeding than other direct oral anticoagulants: a nationwide propensity score-weighted study. Ann Intern Med. 2021, 174:1493-502. 10.7326\/M21-1474","journal-title":"Ann Intern Med"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1055\/s-0039-1693473","article-title":"Decreasing tumor growth and angiogenesis by inhibition of coagulation","volume":"45","author":"Nadir Y","year":"2019","unstructured":"Nadir Y. Decreasing tumor growth and angiogenesis by inhibition of coagulation. Semin Thromb Hemost. 2019, 45:622-8. 10.1055\/s-0039-1693473","journal-title":"Semin Thromb Hemost"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-019-42738-1","article-title":"Low molecular weight heparin and direct oral anticoagulants influence tumour formation, growth, invasion and vascularisation by separate mechanisms","volume":"9","author":"Featherby S","year":"2019","unstructured":"Featherby S, Xiao YP, Ettelaie C, Nikitenko LL, Greenman J, Maraveyas A. Low molecular weight heparin and direct oral anticoagulants influence tumour formation, growth, invasion and vascularisation by separate mechanisms. Sci Rep. 2019, 9:6272. 10.1038\/s41598-019-42738-1","journal-title":"Sci Rep"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.18632\/oncotarget.13300","article-title":"Thrombin inhibition and cisplatin block tumor progression in ovarian cancer by alleviating the immunosuppressive microenvironment","volume":"7","author":"Alexander ET","year":"2016","unstructured":"Alexander ET, Minton AR, Peters MC, van Ryn J, Gilmour SK. Thrombin inhibition and cisplatin block tumor progression in ovarian cancer by alleviating the immunosuppressive microenvironment. Oncotarget. 2016, 7:85291-305. 10.18632\/oncotarget.13300","journal-title":"Oncotarget"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.2119\/molmed.2016.00214","article-title":"Dabigatran potentiates gemcitabine-induced growth inhibition of pancreatic cancer in mice","volume":"23","author":"Shi K","year":"2017","unstructured":"Shi K, Damhofer H, Daalhuisen J, Ten Brink M, Richel DJ, Spek CA. Dabigatran potentiates gemcitabine-induced growth inhibition of pancreatic cancer in mice. Mol Med. 2017, 23:13-23. 10.2119\/molmed.2016.00214","journal-title":"Mol Med"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0185035","article-title":"In vitro effects of apixaban on 5 different cancer cell lines","volume":"12","author":"Guasti L","year":"2017","unstructured":"Guasti L, Squizzato A, Moretto P, et al.. In vitro effects of apixaban on 5 different cancer cell lines. PLoS One. 2017, 12:e0185035. 10.1371\/journal.pone.0185035","journal-title":"PLoS One"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.3904\/kjim.2018.290","article-title":"Gastroprotective effects of irsogladine maleate on ethanol\/hydrochloric acid induced gastric ulcers in mice","volume":"36","author":"Kwon SC","year":"2021","unstructured":"Kwon SC, Kim JH. Gastroprotective effects of irsogladine maleate on ethanol\/hydrochloric acid induced gastric ulcers in mice. Korean J Intern Med. 2021, 36:67-75. 10.3904\/kjim.2018.290","journal-title":"Korean J Intern Med"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1111\/bcp.12911","article-title":"The association between non-vitamin K antagonist oral anticoagulants and gastrointestinal bleeding: a meta-analysis of observational studies","volume":"82","author":"He Y","year":"2016","unstructured":"He Y, Wong IC, Li X, Anand S, Leung WK, Siu CW, Chan EW. The association between non-vitamin K antagonist oral anticoagulants and gastrointestinal bleeding: a meta-analysis of observational studies. Br J Clin Pharmacol. 2016, 82:285-300. 10.1111\/bcp.12911","journal-title":"Br J Clin Pharmacol"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.3892\/etm.2020.9335","article-title":"Reducing upper digestive bleeding risk in patients treated with direct oral anticoagulants and concomitant infection with Helicobacter pylori","volume":"20","author":"Suceveanu AI","year":"2020","unstructured":"Suceveanu AI, Suceveanu AP, Parepa I, et al.. Reducing upper digestive bleeding risk in patients treated with direct oral anticoagulants and concomitant infection with Helicobacter pylori. Exp Ther Med. 2020, 20:205. 10.3892\/etm.2020.9335","journal-title":"Exp Ther Med"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1111\/hel.12990","article-title":"Risk of hospitalization for upper gastrointestinal bleeding in Helicobacter pylori eradicated patients newly started on warfarin or direct oral anticoagulants: a population-based cohort study","volume":"28","author":"Jiang F","year":"2023","unstructured":"Jiang F, Ju C, Guo CG, et al.. Risk of hospitalization for upper gastrointestinal bleeding in Helicobacter pylori eradicated patients newly started on warfarin or direct oral anticoagulants: a population-based cohort study. Helicobacter. 2023, 28:e12990. 10.1111\/hel.12990","journal-title":"Helicobacter"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.1161\/JAHA.120.017559","article-title":"Direct oral anticoagulant use: a practical guide to common clinical challenges","volume":"9","author":"Chen A","year":"2020","unstructured":"Chen A, Stecker E, A Warden B. Direct oral anticoagulant use: a practical guide to common clinical challenges. J Am Heart Assoc. 2020, 9:e017559. 10.1161\/JAHA.120.017559","journal-title":"J Am Heart Assoc"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/191694-the-effect-of-direct-oral-anticoagulants-on-gastric-mucosa-and-helicobacter-pylori-prevalence-in-dyspeptic-patients-a-retrospective-cross-sectional-study","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T20:08:26Z","timestamp":1707509306000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/191694-the-effect-of-direct-oral-anticoagulants-on-gastric-mucosa-and-helicobacter-pylori-prevalence-in-dyspeptic-patients-a-retrospective-cross-sectional-study"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,10,4]]},"references-count":22,"URL":"https:\/\/doi.org\/10.7759\/cureus.46477","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2023,10,4]]}}}